Voyager Therapeutics, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Voyager Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Voyager Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1.2M, a 11.3% increase year-over-year.
  • Voyager Therapeutics, Inc. annual Depreciation for 2023 was $4.44M, a 28.3% decline from 2022.
  • Voyager Therapeutics, Inc. annual Depreciation for 2022 was $6.19M, a 19.9% increase from 2021.
  • Voyager Therapeutics, Inc. annual Depreciation for 2021 was $5.17M, a 35.3% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.44M -$1.75M -28.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $6.19M +$1.03M +19.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $5.17M +$1.35M +35.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $3.82M +$1.05M +38% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $2.77M +$648K +30.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $2.12M +$522K +32.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.6M +$983K +161% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $612K +$12K +2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $600K +$416K +226% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $184K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.